Please use this identifier to cite or link to this item: http://hdl.handle.net/10201/22512

Full metadata record
DC FieldValueLanguage
dc.contributor.authorLambropoulou, M.es
dc.contributor.authorAlexiadis, G.es
dc.contributor.authorLimberis, V.-
dc.contributor.authorNikolettos, N.-
dc.contributor.authorTripsianis, G.-
dc.date.accessioned2011-06-30T12:00:45Z-
dc.date.available2011-06-30T12:00:45Z-
dc.date.issued2005-
dc.identifier.issn0213-3911es
dc.identifier.urihttp://hdl.handle.net/10201/22512-
dc.description.abstractBackgroud: Endometrial carcinoma is the most common malignancy of the female genital tract in the Western world. COX-2 is highly expressed in endometrial carcinoma, but there is controversy regarding its clinical role and its possible prognostic role. COX-2 expression was determined by immunohistochemistry and was correlated to standard clinicopathologic variables in a series of primary untreated endometrial carcinoma patients. COX-2 as an accurate predictor of the disease was also analyzed. Methods: One-hundred and ten cases of primary untreated endometrial carcinoma hosts who were admitted to the Department of Obstetrics and Gynecology, University General Hospital of Alexandroupolis, were investigated. Immunohistochemistry was performed using rabbit polyclonal antiserum against human COX-2. Results: Twenty-eight patients (25.5%) were scored as COX-2 positive. A statistically significant association was found between COX-2 overexpression and FIGO stage (p=0.010). A positive correlation was also found with histological grade (p=0.019) and myometrial invasion (p=0.026). No significant association was found with histologic type of the tumor (p=0.164). COX-2 positive patients had a significant association with sort survival (p=0.028). Conclusions: COX-2 expression is an independent clinicopathologic factor and an independent prognostic factor in endometrial carcinoma. It could be used to plan treatment modalities for hosts.es
dc.formatapplication/pdfes
dc.format.extent7es
dc.languageenges
dc.publisherMurcia : F. Hernándezes
dc.relation.ispartofHistology and histopathologyes
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectEndometrial canceres
dc.subjectImmunohistochemistryes
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicinaes
dc.titleClinicopathologic and prognostic significance of cyclooxygenase-2 expression in endometrial carcinomaes
dc.typeinfo:eu-repo/semantics/articlees
Appears in Collections:Vol.20, nº 3 (2005)

Files in This Item:
File Description SizeFormat 
Clinicopathologic and prognostic significance of.pdf2,36 MBAdobe PDFThumbnail
View/Open


Items in Digitum are protected by copyright, with all rights reserved, unless otherwise indicated.